Rick Blum is meticulous about planning, ordering, and taking the medication he is prescribed to slow the progression of ...

The usual Ocrevus dosage for multiple sclerosis (MS) and clinically isolated syndrome is two starting infusions given 2 weeks apart, and then an infusion every 6 months. Ocrevus (ocrelizumab ...

Millions of Americans who receive intravenous treatment for multiple sclerosis, blood diseases and rheumatologic conditions ...

The Multiple Sclerosis Treatment Optimization Program (MSTOP) was motivated by research showing that Black and Hispanic ...

Multiple sclerosis is a chronic condition affecting ... approved the first DMT for people with PPMS. This infusion drug, ocrelizumab (Ocrevus), can also be used to treat RRMS.

According to the National Multiple Sclerosis Society (NMSS), MS is a chronic autoimmune disease that affects the central ...

Levels of B-cells can help to predict the risk of disability progression independent of relapse activity in relapsing MS ...

Roche Holdings AG (OTC:RHHBY) on Tuesday released statistically significant final overall survival (OS) results from the phase III APHINITY study in people with human epidermal growth factor receptor ...

Morton Village Plaza in Plainview underwent a $2 million renovation between 2023 and last year, property management said.

New evidence added to the literature that paramagnetic rim lesions (PRLs) may be a biomarker of disability accumulation in ...